Markets › LSE › AREC.L

Arecor Therapeutics plc

LSE:AREC.LHealthcareFTSE:AXX

£0.8250+0.00%At closeAt close · Tue 20 Oct · ≈ AED 4.03 · Market cap $49.76M · Next earnings Tue 27 Apr

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	100.0%	100.0%	100.0%	100.0%	30.5%	61.3%	—	—
Operating margin	−201.9%	−516.1%	−485.2%	−200.6%	−211.7%	−272.2%	−272.2%	+0.0 pts
Net margin	−162.1%	−532.7%	−385.4%	−187.1%	−202.6%	38.7%	38.7%	+0.0 pts
EBITDA margin	−191.9%	−541.2%	−418.7%	−183.5%	−200.9%	−259.7%	—	—
Return on equity	−355.7%	−33.3%	−53.1%	−89.8%	−191.4%	10.3%	10.3%	+0.0 pts
Return on assets	−64.3%	−29.5%	−42.5%	−55.6%	−117.4%	8.2%	8.2%	+0.0 pts
Return on capital employed	−119.2%	−32.0%	−64.6%	−89.7%	−195.7%	−71.9%	—	—
Debt / equity	2.6×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	46.6%	1.1%	1.3%	2.2%	2.7%	1.2%	—	—
Interest coverage	−39.4×	−11.8×	−555.2×	−611.7×	−486.2×	−424.2×	—	—
Current ratio	2.7×	9.0×	4.7×	2.2×	2.5×	4.3×	4.3×	+0.0%
Quick ratio	2.7×	9.0×	4.4×	2.0×	2.4×	4.3×	—	—
Cash ratio	2.1×	8.1×	1.3×	1.0×	1.0×	1.9×	1.9×	+0.0%
Asset turnover	0.4×	0.1×	0.1×	0.3×	0.6×	0.2×	—	—
Inventory turnover	0.0×	—	0.3×	4.3×	7.3×	—	—	—
Receivables turnover	16.6×	1.5×	3.6×	1.6×	1.8×	2.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—